CRH Medical Corp (CRHM) Rating Lowered to C+ at TheStreet

CRH Medical Corp (NYSEARCA:CRHM) was downgraded by analysts at TheStreet from a “b-” rating to a “c+” rating in a report released on Friday.

CRHM has been the topic of several other research reports. CIBC lowered shares of CRH Medical Corp from a “sector outperform” rating to a “sector perform” rating in a research report on Monday, July 17th. Canaccord Genuity reduced their target price on shares of CRH Medical Corp from $8.00 to $5.00 and set a “buy” rating for the company in a research note on Friday. Scotiabank downgraded shares of CRH Medical Corp from an “outperform” rating to a “sector perform” rating in a research note on Friday, July 14th. Zacks Investment Research downgraded shares of CRH Medical Corp from a “hold” rating to a “sell” rating in a research note on Tuesday, April 11th. Finally, Royal Bank Of Canada upgraded shares of CRH Medical Corp from a “sector perform” rating to an “outperform” rating in a research note on Friday, July 21st. Three investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $8.13.

CRH Medical Corp (NYSEARCA:CRHM) opened at 2.60 on Friday. The company has a 50-day moving average of $4.77 and a 200-day moving average of $6.37. CRH Medical Corp has a 52 week low of $2.50 and a 52 week high of $9.25.

COPYRIGHT VIOLATION WARNING: “CRH Medical Corp (CRHM) Rating Lowered to C+ at TheStreet” was first posted by Markets Daily and is the sole property of of Markets Daily. If you are viewing this article on another site, it was copied illegally and reposted in violation of United States & international trademark and copyright law. The correct version of this article can be read at https://www.themarketsdaily.com/2017/08/08/crh-medical-corp-crhm-rating-lowered-to-c-at-thestreet.html.

Several institutional investors have recently bought and sold shares of CRHM. Canada Pension Plan Investment Board purchased a new position in shares of CRH Medical Corp during the second quarter valued at approximately $683,000. TD Asset Management Inc. boosted its position in shares of CRH Medical Corp by 57.7% in the second quarter. TD Asset Management Inc. now owns 67,203 shares of the company’s stock valued at $382,000 after buying an additional 24,596 shares in the last quarter. ARP Americas LLC boosted its position in shares of CRH Medical Corp by 119.6% in the second quarter. ARP Americas LLC now owns 28,642 shares of the company’s stock valued at $163,000 after buying an additional 15,600 shares in the last quarter. Sei Investments Co. purchased a new position in shares of CRH Medical Corp during the second quarter valued at approximately $852,000. Finally, Mawer Investment Management Ltd. boosted its position in shares of CRH Medical Corp by 24.2% in the second quarter. Mawer Investment Management Ltd. now owns 4,742,491 shares of the company’s stock valued at $26,999,000 after buying an additional 924,540 shares in the last quarter.

CRH Medical Corp Company Profile

CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.

Analyst Recommendations for CRH Medical Corp (NYSEARCA:CRHM)

Receive News & Ratings for CRH Medical Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Corp and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply